BIOME - Home
In accordance with the latest NRW government and University of Duisburg-Essen health and safelty regulations, all BIOME lectures and seminars have resumed digitally as from 20.04.2020. The core-specific, "biome@home" programmes are scheduled to run until physical teaching is once again possible.
Furthermore, please kindly address all BIOME applications and any other communication to email@example.com@home
The Medical Faculty's annual Research Day went digital this year and was well-supported with the participation of 175 doctoral students and 70 reviewers in 17 groups as well as more than 600 spectators. BIOME-affiliated poster prize winners included Anna-Lena Beerlage, Eva Boog-Whiteside, Marvin Droste, Jana-Fabienne Ebel, Lena Gockeln, Anne Günther, Nhi Ngo Thi Phuong, Theresa Quinting, Armin Spomer, Johannes Wilhelmi and Jiajin Yang. Special mention should be made here of Beatrice Thier and Rebekka Vogtmann for the outstanding achievement of each being awarded a poster prize for the third year in a row, and of Venkatesh Kumar Murugasan who was a runner-up in the science slam. Excellent work, and congratulations to all.
18-20.11.2020 1st BIOME Virtual Retreat
The Covid-19 pandemic did not hinder the triple BIOME cores for Cellular and Molecular Immunology/Infectious Diseases/Tumour and Signalling from holding their annual interdisciplinary retreat this year, which, due to lockdown, took place held virtually on three intensive, consecutive mornings. The retreat's programme was adapted to suit the format accordingly: instead of the usual talk and poster sessions, each doctoral member was given a strictly-scheduled, four-minute talk slot in which to present their research's punchline, with a further two minutes for peer discussion thereafter. The sessions were sovereignly hosted by doctoral chairs, with discussion panel members being announced at the beginning of each session. This year's keynote speaker was Toni Cathomen (University of Freiburg) who gave a fascinating overview of the clinical translation of genome editing. Prizes for each day's best doctoral presentation were awarded to Nina Buß, Keven Hörster and Beatrice Thier.
© For the kind permission of the SARS-CoV-2 image used in the collage above, BIOME would like to thank the following scientists:
Maren Bormann1, Lukas van de Sand1, Leonie Schipper1, Bernd Walkenfort2 and PD Dr. rer. nat. Adalbert Krawczyk1 from the 1Department of Infectious Diseases and the 2Electron Microscopy Unit (EMU) of the IMCES, University of Duisburg-Essen, Germany.
The international excellence of biomedical research at the University of Duisburg-Essen is reflected in the latest US News & World Report on the Best Global Universities with three listings in the top 100 subject rankings for Oncology (# 15), Cardiac and Cardiovascular Systems (# 57) and Radiology, Nuclear Medicine and Medical Imaging (# 70) in particular.
At the end of 2018, the Science Council already highlighted the great potential and the highly positive development at the Medical Faculty of the University of Duisburg-Essen and the University Hospital Essen in recent years and emphasised the location's success in research. “The very good placement in this important international ranking confirms that we have chosen the right path so far,” states the Dean of the the Medical Faculty, Prof. Jan Buer.
Clinical Medicine at the University Hospital Essen also performed notably: it is the front runner in North Rhine Westphalia, is ranked 8th in the top 10 in Germany and reached 129th place worldwide.
Compared with the 1 500 universities included in the ranking, UDE is 5th in NRW, 21st in Germany, 124th in Europe, and 285th worldwide.
The Fritz Schiff Prize 2020 was awarded to Dr. Esther Schwich from the Institute for Transfusion Medicine. She received the EUR 3 000 prize of the German Society for Transfusion Medicine and Immunohematology for her doctoral and subsequent project work in the field of transfusion medicine, which was funded by the BIOME-PEP excellence programme of the Medical Faculty.
The focus of the investigations she carried out was the surface molecule HLA-G present on blood cells and its properties as an immune checkpoint molecule. "With this study we were able to gain important insights for an improved understanding of the course of the disease and possible new therapeutic approaches for breast and ovarian cancer," explains the young scientist, Dr. Esther Schwich.
In addition to the brilliant and diverse line-up of BIOME alumni speakers who joined us from Tarrytown (NY), Stockholm, Zurich, Oxford, Yale and Trinity College Dublin as well as from various parts of Germany, confirmed keynote guest speakers at this highly successful combined physical/digital event were Maija Hollmén (University of Turku, FI), Eran Elinav (Weizmann Institute of Science, Rehovot, IL) and Ali Ertürk (Helmholtz Zentrum München, DE).
BIOME extends a huge, big thanks to each of our alumni and keynote guest speakers for so kindly sharing their career experiences and job/research insights with the members of our graduate school at this occasion. It was trully a wonderful and inspiring event to mark BIOME's 10th anniversary, and we very much appreciate the time, efforts and thoughtful contributions that made this (alas hybrid) conference work. It was our privilege to have you as our guests. Thank you to everybody for joining us, and wishing all participants every success in continuing their impressive professional endeavours.
BIOME warmly welcomes the collaborative research centres, CRC 289: Treatment Expectation (Speaker: Ulrike Bingel) and CRC 296: Local Thyroid Hormone Action (Speakers: Dagmar Führer-Sakel and Heike Heuer) as independent research and training structures to our graduate school network. These long-term multidisciplinary scientific programmes are funded by the German Research Foundation (DFG).
Patients’ expectations about treatment benefits are important modulators of health outcomes. An individual’s expectation can substantially shape symptoms and disease progression and influence the efficacy and tolerability of treatments. The ultimate goal of the CRC 289: Treatment Expectation is to generate the knowledge base for the systematic utilisation of patients’ expectation in order to optimise therapeutic strategies and thereby improve health outcomes.
Thyroid hormones (TH) are essential for normal tissue homeostasis since they orchestrate many cellular processes. Both TH deficiency and TH excess result in a vast array of clinical manifestations indicating that proper organ functions are compromised. While current treatment strategies aim to normalise circulating TH levels in affected patients, recent discoveries have highlighted the importance of local mechanisms in controlling the organ-specific TH status. Hence, the goals of the CRC 296: Local Thyroid Hormone Action (Locotact) are to dissect how these local control mechanisms are organised, as well as to address whether a local modulation of TH action is beneficial in certain pathologies.
At a Glance
The most important information at your fingertips
The Graduate School of Biomedical Science at the University of Duisburg-Essen in Germany has been founded to integrate all PhD and MD graduates within the Faculties of Biology and Medicine into a cutting-edge interdisciplinary study programme tailored to ensure that they receive an outstanding, globally focused academic education. Additionally, we have created an intramural umbrella organisation for the research foci through the erection of a synergetic framework between the research training groups (RTGs) and the BIOME thematic cores. The university’s internal drive to provide structures furthering soft skills, gender equality and family-oriented support additionally contributes to an excellent, all-round tertiary environment.Read more